Vertex Pharmaceuticals (VRTX)
NASDAQ: VRTX
· Real-Time Price · USD
450.65
-4.80 (-1.05%)
At close: Jun 16, 2025, 1:44 PM
-1.05% (1D)
| Bid | 450.18 |
| Market Cap | 115.73B |
| Revenue (ttm) | 11.1B |
| Net Income (ttm) | -988.9M |
| EPS (ttm) | -3.83 |
| PE Ratio (ttm) | -117.66 |
| Forward PE | 22.09 |
| Analyst | Buy |
| Ask | 450.56 |
| Volume | 473,117 |
| Avg. Volume (20D) | 1,699,336 |
| Open | 455.31 |
| Previous Close | 455.45 |
| Day's Range | 450.02 - 457.23 |
| 52-Week Range | 377.85 - 519.88 |
| Beta | 0.42 |
About VRTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol VRTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for VRTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-10.03%
Vertex Pharmaceuticals shares are trading lower af...
Unlock content with
Pro Subscription
1 month ago
-0.19%
Vertex Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q1 financial results.
